GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Brain Scientific Inc (OTCPK:BRSF) » Definitions » Beta

Brain Scientific (Brain Scientific) Beta : N/A (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Brain Scientific Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-05), Brain Scientific's Beta is Not available.


Brain Scientific Beta Historical Data

The historical data trend for Brain Scientific's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain Scientific Beta Chart

Brain Scientific Annual Data
Trend Dec21 Dec22
Beta
- -

Brain Scientific Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Beta Get a 7-Day Free Trial - - - - -

Competitive Comparison of Brain Scientific's Beta

For the Medical Devices subindustry, Brain Scientific's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brain Scientific's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Brain Scientific's Beta distribution charts can be found below:

* The bar in red indicates where Brain Scientific's Beta falls into.



Brain Scientific Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Brain Scientific  (OTCPK:BRSF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Brain Scientific Beta Related Terms

Thank you for viewing the detailed overview of Brain Scientific's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Brain Scientific (Brain Scientific) Business Description

Traded in Other Exchanges
N/A
Address
6700 Professional Parkway, Lakewood Ranch, FL, USA, 34240
Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
Executives
Morgan C. Frank 10 percent owner 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02110
Manchester Explorer, L.p. 10 percent owner MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
James E Besser 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114
Jeb Partners, L.p. 10 percent owner MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Management Pr, Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114
Donald S Mackenzie director 5251 FISHER ISLAND DRIVE, MIAMI BEACH FL 33109
Thomas Olivier director C/O ARROWROOT ACQUISITION CORP., 4553 GLENCOE AVE SUITE 200, MARINA DEL REY CA 90292
Farid Anthony officer: Chief Technology Officer 12041 NW 49TH DRIVE, CORAL SPRINGS FL 33076
Daniel Danny Cloutier director 1200 MC GILL COLLEGE AVENUE, SUITE 1100, MONTREAL A8 H3G4G7
Bonnie-jeanne Gerety officer: Chief Financial Officer 5255 SOUTH TRIMBLE RD, SANDY SPRINGS GA 30342
Hassan Kotob director, 10 percent owner, officer: Chief Executive Officer 125 WILBUR PLACE, SUITE 170, C/O BRAIN SCIENTIFIC INC., BOHEMIA NY 11716
Mark Corrao officer: Chief Financial Officer 531 AIRPORT NORTH OFFICE PARK, FORT WAYNE IN 46825
Boris Goldstein director, 10 percent owner, officer: Chairman of the Board & EVP 45 WEST34 ST. 800, NEW YORK NY 10001
Nickolay V. Kukekov director 4524 WESTWAY AVE, DALLAS TX 75205

Brain Scientific (Brain Scientific) Headlines